Traders are waiting for U.S. and Iranian officials to meet in Switzerland on Friday, when they are expected to sign an initial agreement and begin a 60-day cease-fire.
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
